<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="cfr.xsl"?>
<CFRGRANULE xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="CFRMergedXML.xsd">
  <FDSYS>
    <CFRTITLE>40</CFRTITLE>
    <CFRTITLETEXT>Protection of Environment</CFRTITLETEXT>
    <VOL>30</VOL>
    <DATE>2007-07-01</DATE>
    <ORIGINALDATE>2007-07-01</ORIGINALDATE>
    <COVERONLY>false</COVERONLY>
    <TITLE>Phenol, 4,4â²-methy-lenebis (2,6-dimethyl-.</TITLE>
    <GRANULENUM>721.5740</GRANULENUM>
    <HEADING>Section 721.5740</HEADING>
    <ANCESTORS>
      <PARENT HEADING="Title 40" SEQ="4">Protection of Environment</PARENT>
      <PARENT HEADING="CHAPTER I" SEQ="3">ENVIRONMENTAL PROTECTION AGENCY (CONTINUED)</PARENT>
      <PARENT HEADING="SUBCHAPTER R" SEQ="2">TOXIC SUBSTANCES CONTROL ACT</PARENT>
      <PARENT HEADING="PART 721" SEQ="1">SIGNIFICANT NEW USES OF CHEMICAL SUBSTANCES</PARENT>
      <PARENT HEADING="Subpart E" SEQ="0">Significant New Uses for Specific Chemical Substances</PARENT>
    </ANCESTORS>
  </FDSYS>
  <SECTION>
    <SECTNO>§ 721.5740</SECTNO>
    <SUBJECT>Phenol, 4,4′-methy-lenebis (2,6-dimethyl-.</SUBJECT>
    <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as Phenol, 4,4′-methylenebis (2,6-dimethyl- (PMNs P-88-864, P-90-211, and P-94-921; CAS No. 5384-21-4) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
    <P>(2) The significant new uses are:</P>
    <P>(i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(ii), (a)(5)(iv), (a)(5)(v), (a)(6)(i), (b) (concentration set at 1 percent), and (c).</P>
    <P>(ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1 percent), (f), (g)(1)(iv), (g)(2)(iv), (g)(2)(v), (g)(3)(ii), (g)(4)(iii), and (g)(5). The label and MSDS as required by this paragraph shall also include the following statements: This substance may cause blood effects. This substance may cause chronic effects.</P>
    <P>(iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (g), (l), and (q).</P>
    <P>(iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1).</P>
    <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
    <P>(1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), (e), (f), (g), (h), (i), and (k) are applicable to manufacturers, importers, and processors of this substance.<PRTPAGE P="372"/>
    </P>
    <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section.</P>
    <P>(3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section.</P>
    <CITA>[55 FR 33306, Aug. 15, 1990. Redesignated and amended at 58 FR 29946, 29947, May 24, 1993; 58 FR 34204, June 23, 1993; 63 FR 45956, Aug. 28, 1998]</CITA>
  </SECTION>
</CFRGRANULE>

